Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Review article: predicting response in hepatitis C virus therapy.

U Mihm1, E Herrmann, C Sarrazin

  • 1Department of Internal Medicine II, Saarland University, Homburg/Saar, Germany.

Alimentary Pharmacology & Therapeutics
|April 14, 2006
PubMed
Summary

Combination therapy improves chronic hepatitis C treatment, but sustained virologic response rates remain suboptimal. Viral load and genotype 1 are key predictors, with early RNA quantification offering better outcome prediction.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Thyroid dose guidance in elective supraclavicular breast radiotherapy: a national survey of practice patterns in Switzerland.

Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]·2026
Same author

"France's 10-year journey with mid-urethral slings: The rise of the TVT".

The French journal of urology·2025
Same author

[Strategietreffen: Virushepatitis in Deutschland eliminieren].

Zeitschrift fur Gastroenterologie·2023
Same author

The shifting shelf task: a new, non-verbal measure for attentional set shifting.

Proceedings. Biological sciences·2023
Same author

Heterotopia in Individuals with 22q11.2 Deletion Syndrome.

AJNR. American journal of neuroradiology·2021
Same author

Age-dependent gene expression of Calliphora vicina pupae (Diptera: Calliphoridae) at constant and fluctuating temperatures.

International journal of legal medicine·2021

Area of Science:

  • Hepatology
  • Virology
  • Pharmacology

Background:

  • Combination therapy with pegylated interferons and ribavirin has advanced chronic hepatitis C treatment.
  • However, sustained virologic response (SVR) rates remain suboptimal, ranging from 54-63% in treated patients.
  • Treatment success is further limited in specific patient subpopulations due to various viral and host factors.

Purpose of the Study:

  • To summarize virus- and patient-related prognostic parameters for antiviral therapy response in chronic hepatitis C.
  • To emphasize the predictive value of hepatitis C virus RNA quantification during therapy for treatment outcomes.

Main Methods:

  • Review of existing literature on prognostic factors in chronic hepatitis C treatment.
  • Analysis of viral factors (genotype, viral load) and patient factors (cirrhosis) influencing treatment response.

Related Experiment Videos

  • Evaluation of the role of early hepatitis C virus RNA quantification in predicting treatment outcomes.

    • Main Results:

    • Hepatitis C virus genotype 1 infection and high baseline viral load are major viral factors associated with impaired response.
    • Cirrhosis is a significant patient-related factor negatively impacting treatment success.
    • Baseline predictors of SVR become less critical when early on-treatment hepatitis C virus RNA levels are considered.

    Conclusions:

    • Hepatitis C virus RNA quantification during early therapy is a powerful tool for predicting treatment response.
    • Understanding and monitoring viral and patient factors are crucial for optimizing chronic hepatitis C treatment strategies.
    • Further research into personalized treatment approaches based on these predictive factors is warranted.